Galventa GmbH

Develops cutting edge nutraceutical and pharmaceutical products.

Launch date

May 2018

Employees

Market cap

Enterprise valuation

Canton of St. Gallen Switzerland (HQ)

Revenues, earnings & profits over time

EUR	2018
Revenues	4.4m

Date	Investors	Amount	Round
-	Venture Kick Kickfund	N/A	-
May 2021	N/A	$354k	Convertible
Oct 2021	Gen Ilac	€700k	Seed
May 2023*	Innosuisse	N/A	Grant
Total Funding		€1.0m

Tech stackLearn more about the technologies and tools that this company uses.

Financials